George Leonard Baker's most recent trade in Corcept Therapeutics Inc was a trade of 15,000 Stock Option (Right To Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc | George Leonard Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 15,000 | 15,000 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 207 | 1,046,631 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 207 | 955,262 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 21.53 per share. | 11 Jun 2021 | 100,000 | 3,308,303 (2%) | 0% | 21.5 | 2,153,000 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 21.53 per share. | 11 Jun 2021 | 50,000 | 1,046,838 (0%) | 0% | 21.5 | 1,076,500 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 30,000 | 0 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 18 May 2021 | 30,000 | 1,026,838 (0%) | 0% | 6.6 | 196,500 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.42 per share. | 18 May 2021 | 30,000 | 1,056,838 (0%) | 0% | 4.4 | 132,600 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. | 18 May 2021 | 30,000 | 1,086,838 (0%) | 0% | 4.1 | 121,500 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 18 May 2021 | 30,000 | 1,116,838 (0%) | 0% | 1.7 | 52,200 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 18 May 2021 | 30,000 | 1,146,838 (1%) | 0% | 1.7 | 52,200 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 30,000 | 0 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 30,000 | 0 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 30,000 | 0 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 30,000 | 0 | - | - | Stock Option (Right To Buy) | |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 22.80 per share. | 30 Nov 2020 | 1,109 | 3,208,235 (2%) | 0% | 22.8 | 25,285 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 22.65 per share. | 30 Nov 2020 | 68 | 3,208,303 (2%) | 0% | 22.6 | 1,540 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 22.81 per share. | 25 Nov 2020 | 361 | 3,207,126 (2%) | 0% | 22.8 | 8,233 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 22.93 per share. | 23 Nov 2020 | 1,551 | 3,205,336 (2%) | 0% | 22.9 | 35,562 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 22.93 per share. | 23 Nov 2020 | 1,429 | 3,206,765 (2%) | 0% | 22.9 | 32,766 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 17.91 per share. | 18 Nov 2020 | 2,372 | 3,203,785 (2%) | 0% | 17.9 | 42,491 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 17.82 per share. | 13 Nov 2020 | 7,883 | 3,201,413 (2%) | 0% | 17.8 | 140,469 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 17.94 per share. | 13 Nov 2020 | 200 | 3,193,530 (2%) | 0% | 17.9 | 3,588 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 17.71 per share. | 09 Nov 2020 | 15,000 | 3,193,330 (2%) | 0% | 17.7 | 265,635 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 17.96 per share. | 09 Nov 2020 | 3,786 | 3,178,330 (2%) | 0% | 18.0 | 68,013 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 17.98 per share. | 06 Nov 2020 | 13,500 | 3,174,544 (2%) | 0% | 18.0 | 242,665 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 12.50 per share. | 28 Aug 2020 | 25,807 | 3,161,044 (2%) | 0% | 12.5 | 322,526 | Common Stock |
| Corcept Therapeutics Inc | George Leonard Baker | Director | Purchase of securities on an exchange or from another person at price $ 12.48 per share. | 28 Aug 2020 | 20,444 | 3,135,237 (2%) | 0% | 12.5 | 255,213 | Common Stock |